Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands.

The Journal of biological chemistry - 30 Oct 2009

Lee Erinna F, Czabotar Peter E, Yang Hong, Sleebs Brad E, Lessene Guillaume, Colman Peter M, Smith Brian J, Fairlie W Douglas

Abstract excerpt

Antagonists of anti-apoptotic Bcl-2 family members hold promise as cancer therapeutics. Apoptosis is triggered when a peptide containing a BH3 motif or a small molecule BH3 peptidomimetic, such as ABT 737, binds to the relevant Bcl-2 family members. ABT-737 is an antagonist of Bcl-2, Bcl-x(L), an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to bcl-X Protein
Share to Biphenyl Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloid Cell Leukemia Sequence 1 Protein

Share to Nitrophenols

Share to Piperazines

Share to Proto-Oncogene Proteins c-bcl-2

Share to Sulfonamides

Source

Open in PubMed Open full text

Identifiers

PMID: 19726685
DOI: 10.1074/jbc.M109.040725
PMCID: PMC2781605

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19726685-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands.PMID 19726685Read ↗

Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancerSemantic proximity Read ↗

Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.Semantic proximity Read ↗

Structural insights into chemoresistance mutants of BCL-2 and their targeting by stapled BAD BH3 helices.Semantic proximity Read ↗

Structural Details of BH3 Motifs and BH3-Mediated Interactions: an Updated PerspectiveSemantic proximity Read ↗

The BCL-2 arbiters of apoptosis and their growing role as cancer targetsSemantic proximity Read ↗

Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1.Semantic proximity Read ↗

Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell MalignanciesSemantic proximity Read ↗

Structure-based redesign of the binding specificity of anti-apoptotic Bcl-x(L).Semantic proximity Read ↗

BH3 Mimetics for the Treatment of B-Cell Malignancies—Insights and Lessons from the ClinicSemantic proximity Read ↗

Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.Semantic proximity Read ↗

Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement.Semantic proximity Read ↗

Completing the family portrait of the anti‐apoptotic Bcl‐2 proteins: Crystal structure of human Bfl‐1 in complex with BimSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.